News Archive http://egalet.investorroom.com/ Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products http://egalet.investorroom.com/2018-10-31-Egalet-Signs-Asset-Purchase-Agreement-to-Acquire-Four-FDA-Approved-Non-Narcotic-Pain-Products --Anticipates projected pro forma annual net revenue of between $80 and $90 million-- Wed, 31 Oct 2018 06:04:00 -0400 http://egalet.investorroom.com/2018-10-31-Egalet-Signs-Asset-Purchase-Agreement-to-Acquire-Four-FDA-Approved-Non-Narcotic-Pain-Products Egalet Reports Second Quarter 2018 Financial Results http://egalet.investorroom.com/2018-08-08-Egalet-Reports-Second-Quarter-2018-Financial-Results --Improvements in formulary status for key products-- Wed, 08 Aug 2018 06:02:00 -0400 http://egalet.investorroom.com/2018-08-08-Egalet-Reports-Second-Quarter-2018-Financial-Results Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018 http://egalet.investorroom.com/2018-07-25-Egalet-to-Host-Conference-Call-and-Webcast-to-Discuss-Second-Quarter-2018-Financial-Results-on-August-8-2018 Wed, 25 Jul 2018 06:02:00 -0400 http://egalet.investorroom.com/2018-07-25-Egalet-to-Host-Conference-Call-and-Webcast-to-Discuss-Second-Quarter-2018-Financial-Results-on-August-8-2018 Egalet Appoints Industry Veteran John Varian to Board of Directors http://egalet.investorroom.com/2018-06-07-Egalet-Appoints-Industry-Veteran-John-Varian-to-Board-of-Directors Thu, 07 Jun 2018 06:02:00 -0400 http://egalet.investorroom.com/2018-06-07-Egalet-Appoints-Industry-Veteran-John-Varian-to-Board-of-Directors Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference http://egalet.investorroom.com/2018-06-04-Egalet-to-Participate-in-Panels-at-2018-BIO-International-Convention-and-JMP-Life-Sciences-Conference Mon, 04 Jun 2018 06:02:00 -0400 http://egalet.investorroom.com/2018-06-04-Egalet-to-Participate-in-Panels-at-2018-BIO-International-Convention-and-JMP-Life-Sciences-Conference